ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 102 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $174,926,000 | -13.2% | 8,434,232 | 0.0% | 13.47% | -16.5% |
| Q3 2021 | $201,494,000 | -12.5% | 8,434,232 | 0.0% | 16.12% | -24.0% |
| Q2 2021 | $230,170,000 | -24.5% | 8,434,232 | -20.0% | 21.23% | -13.2% |
| Q1 2021 | $305,003,000 | +2.8% | 10,542,790 | 0.0% | 24.46% | +7.1% |
| Q4 2020 | $296,569,000 | -4.0% | 10,542,790 | 0.0% | 22.84% | -17.6% |
| Q3 2020 | $308,904,000 | -3.1% | 10,542,790 | 0.0% | 27.73% | -0.9% |
| Q2 2020 | $318,814,000 | +1.5% | 10,542,790 | 0.0% | 28.00% | -21.4% |
| Q1 2020 | $314,175,000 | – | 10,542,790 | – | 35.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $165,956,000 | 12.78% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $57,330,000 | 6.84% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $10,874,000 | 3.97% |
| Logos Global Management LP | 1,525,000 | $29,143,000 | 3.58% |
| 1492 Capital Management LLC | 178,320 | $3,408,000 | 2.45% |
| Cormorant Asset Management, LP | 1,000,000 | $19,110,000 | 1.34% |
| MPM BioImpact LLC | 257,185 | $4,915,000 | 1.16% |
| Orbimed Advisors | 2,800,000 | $53,508,000 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 220,985 | $4,223,000 | 0.83% |
| Rubric Capital Management LP | 472,047 | $9,021,000 | 0.45% |